Key Point: Postprandial blood glucose levels correlate with hemoglobin A1c values, so lowering postprandial blood glucose levels improves A1c...

This week Par Pharmaceutical announced that they had been granted approval to market generic Starlix (Nateglinide). See this week's New Product. Does the approval of this generic effectively mean we have a new treatment...

"You are who you pretend to be." -------------------------------- Kurt Vonnegut, Jr.  

News Flash:  New Buccal Insulin Approved by the FDA, but with Conditions

A 48-year-old woman who has had Type 2 diabetes mellitus for several years is seen for a routine follow-up evaluation. Her metabolic control has always been very good, with most hemoglobin A1c values less than 6.5%. Her current treatment is...

Cinnamon for Type 2 diabetes works for some. To determine whether cinnamon lowers HbA1c in patients with Type 2 diabetes, researchers performed a randomized, controlled trial of 109 Type 2 diabetic (HbA1c >7.0) pediatric,...

No Car and Easy Access to Fast-Food Restaurants Prompts Weight Gain. A published study suggests that individuals who live close to a fast-food restaurant and do not have access to a car are more likely to have excess...

Raisins Help Protect Your Teeth and Gums. Clinical studies have found that, contrary to the prevailing beliefs that raisins contribute to tooth decay, raisins may actually help protect the teeth and gums. Five compounds (phytochemicals) were...

Generic Starlix™ Gets FDA Approval. Nateglinide, the generic for Starlix, which is indicated in the treatment of Type 2 diabetes, will be made by Par Pharmaceutical. Nateglinide tablets are ...

Generex Biotechnology Corporation, an innovator for drug delivery for metabolic diseases through the inner lining of the mouth, announced that the U.S. FDA has granted approval for the treatment use of Oral-lyn™ under...

In patients with recent onset Type 2 diabetes, treatment with insulin or the diabetes drug metformin did not reduce inflammatory biomarkers, such as high-sensitivity C-reactive protein, although the treatment did improve glucose control,...

Patients taking a novel diet drug that combines the stimulant phentermine with the anticonvulsant, topiramate lost an average of 37 pounds over a year with significant improvement in a number of cardiovascular risk...

We reviewed this information just a couple of weeks ago, but it is important enough to take another look at the results.

Men and women with smaller thighs have an increased risk for heart disease and early death compared with those with larger thighs, according to results of a large cohort study.

An international consortium of scientists has identified a new genetic variant associated with Type 2 diabetes, insulin resistance, and hyperinsulinemia , Dr. Johan Rung Cambridge, UK, and colleagues report.

  An elevated fasting glucose level at hospital admission among patients with acute coronary syndrome (ACS) is associated with increased risk of death and other cardiovascular events up to 6 months later, U.S. researchers...

The widespread recommendation for the routine use of low-dose aspirin in primary prevention of cardiovascular events for all patients with Type 2 diabetes should be revisited, experts said at theEuropean Society of Cardiology 2009...

There are common genetic factors that slightly predispose individuals to develop both periodontal disease and cardiovascular disease, a prospective study of Swedish twins indicates.

Exsulin Corporation announces next hase II trial of novel islet regeneration treatment in Type 1 diabetes. Leading diabetes research centers collaborate on new trial designed to further evaluate regeneration treatment for people with Type 1...

New research indicates that patients with lesser degrees of celiac disease-related symptoms, such as intestinal inflammation or latent celiac disease, have a modestly increased risk of death, according to a study.